Relationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19

dc.contributor.authorKhan, Sikandar H.
dc.contributor.authorPerkins, Anthony J.
dc.contributor.authorChi, Rosalyn
dc.contributor.authorSeyffert, Sarah
dc.contributor.authorConrad, Peter
dc.contributor.authorLindroth, Heidi
dc.contributor.authorWang, Sophia
dc.contributor.authorMulkey, Malissa
dc.contributor.authorGao, Sujuan
dc.contributor.authorKhan, Babar
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-09-20T13:22:30Z
dc.date.available2023-09-20T13:22:30Z
dc.date.issued2023-01-18
dc.description.abstractCritically ill patients with COVID-19 experience high rates of delirium and coma. Whether delirium occurs through novel mechanisms in COVID-19 is not known. We analyzed the relationship among biomarkers of inflammation (C-reactive protein [CRP]), hypercoagulability (d-dimer), and lung macrophage activation (ferritin), and the primary composite outcome of delirium/coma next day. We also measured associations between biomarkers and next day delirium and coma independently, and delirium severity. Design: Retrospective, observational cohort study. Setting: ICUs at two large, urban, academic referral hospitals. Patients: All consecutive adult patients admitted to the ICU from March 1, 2020, to June 7, 2020, with COVID-19 with clinical biomarkers and delirium assessments performed. Interventions: None. Measurements and main results: Daily concentrations of CRP, d-dimer, and ferritin were obtained. Coma (assessed by Richmond Agitation-Sedation Scale) and delirium (assessed by Confusion Assessment Method for the ICU/Confusion Assessment Method for the ICU-7) were measured bid. A cohort of 197 ICU patients with COVID-19 were included. Higher d-dimer (odds ratio [OR], 1.57; 95% CI, 1.17-2.12; p < 0.01) and ferritin quartiles (OR, 1.36; 95% CI, 1.02-1.81; p < 0.01) were associated with greater odds of the composite outcome of delirium/coma next day. d-dimer was associated with greater odds of next day delirium (OR, 1.49; 95% CI, 1.14-1.94; p < 0.01) and coma independently (OR, 1.52; 95% CI, 1.08-2.14; p = 0.017). Higher ferritin quartiles were associated with greater odds of next day delirium (OR, 1.33; 95% CI, 1.04-1.70; p = 0.026) and coma independently (OR, 1.59; 95% CI, 1.14-2.23; p < 0.01). Higher CRP quartiles were associated with coma (OR, 1.36; 95% CI, 1.03-1.79; p = 0.030) and delirium severity the next day (β = 0.30; se, 0.07; p ≤ 0.01). Conclusions: Our hypothesis-generating study found d-dimer and ferritin were associated with delirium/coma the following day, as well as delirium and coma independently. CRP was associated with next day coma and delirium severity. Larger studies to validate these results are needed.
dc.eprint.versionFinal published version
dc.identifier.citationKhan SH, Perkins AJ, Chi R, et al. Relationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19. Crit Care Explor. 2023;5(1):e0851. Published 2023 Jan 18. doi:10.1097/CCE.0000000000000851
dc.identifier.urihttps://hdl.handle.net/1805/35657
dc.language.isoen_US
dc.publisherWolters Kluwer
dc.relation.isversionof10.1097/CCE.0000000000000851
dc.relation.journalCritical Care Explorations
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcePMC
dc.subjectBiomarkers
dc.subjectComa
dc.subjectCOVID-19
dc.subjectCritical care
dc.subjectDelirium
dc.subjectDelirium severity
dc.titleRelationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Khan2023Relationship-CCBYNCND.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: